SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression.

Biochem Biophys Res Commun

Department of Orthopedics, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Pudong, Shanghai, China. Electronic address:

Published: June 2020

Growing studies have indicated the involvements of long noncoding RNAs (lncRNAs) in the initiation and progression of various tumors. We aimed to investigated the role of lncRNA LMCD1 antisense RNA 1 (LMCD1-AS1) in osteosarcoma development. We found that LMCD1-AS1 and SP1 were highly expressed in osteosarcoma tissues and cell lines. High levels of LMCD1-AS1 were correlated with positively metastasis and poor clinical prognosis. Moreover, we showed that SP1 can bind to the promoter region of LMCD1-AS1, resulting in its overexpression in osteosarcoma. Functionally, silencing of LMCD1-AS1 suppressed the proliferation, migration, invasion and EMT progress of osteosarcoma cells. Mechanistic studies revealed that LMCD1-AS1 was a sponge of miR-106b-5p activity. LMCD1-AS1 modulated survival of osteosarcoma via targeting miR-106b-5p. Overall, we firstly indicated that LMCD1-AS1 overexpression contributes to osteosarcoma development and poor clinical outcome, suggesting that LMCD1-AS1 may be a novel diagnostic and prognostic biomarker for osteosarcoma and a target for osteosarcoma therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2020.03.151DOI Listing

Publication Analysis

Top Keywords

lmcd1-as1
10
osteosarcoma
9
osteosarcoma development
8
poor clinical
8
lmcd1-as1 overexpression
8
sp1-mediated upregulation
4
upregulation lncrna
4
lncrna lmcd1-as1
4
lmcd1-as1 functions
4
functions cerna
4

Similar Publications

Objective: To investigate the clinical features, imaging characteristics and molecular profile of Sellar neurocytoma (SN).

Methods: Clinical, imaging, and pathological features of eleven cases of sellar neurocytoma were retrospectively analyzed. Electron microscopy was performed in five cases.

View Article and Find Full Text PDF

LMCD1-AS1 Facilitates Cell Proliferation and EMT by Sponging miR-873-3p in Cervical Cancer.

Crit Rev Eukaryot Gene Expr

February 2023

Department of Gynaecology and Obstetrics, Chongqing General Hospital, Chongqing 401147, China.

Article Synopsis
  • Long non-coding RNA LMCD1-AS1 is found to be highly expressed in cervical cancer (CC) and is linked to more advanced disease stages and poorer patient prognosis.
  • The study shows that inhibiting LMCD1-AS1 can reduce cell growth, migration, and invasion in CC cell lines, highlighting its potential role in cancer progression.
  • LMCD1-AS1 may act as an oncogene by regulating miR-873-3p, suggesting that targeting LMCD1-AS1 could offer new treatment strategies for CC.
View Article and Find Full Text PDF

Purpose: To explore the specific role and regulatory mechanism of oxysterol binding protein like 5 (OSBPL5) in non-small cell lung cancer (NSCLC).

Methods And Results: Quantitative real-time polymerase chain reaction (qRT-PCR) analysis demonstrated that OSBPL5 expression was notably elevated in NSCLC tissues and cell lines, and Kaplan-Meier analysis manifested that high OSBPL5 expression was closely related to the poor prognosis of NSCLC patients. Besides, according to the results from western blot analysis, cell counting kit-8, EdU and Transwell assays, knockdown of OSBPL5 suppressed NSCLC cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process.

View Article and Find Full Text PDF

LMCD1 antisense RNA 1 is a newly identified long noncoding RNA.

Anticancer Drugs

January 2022

Department of Medical Biology and Genetics, Institute of Health Sciences, Gaziantep University, Gaziantep, Turkey.

Long noncoding RNAs (lncRNAs) are one of the interesting fields in cancer researches. LncRNAs are generally dysregulated in many diseases. LMCD1 antisense RNA 1 (LMCD1-AS1) is a newly identified lncRNA with protumorigenic functions on tumor cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!